Treatment of anthracycline extravasation with dexrazoxane - Clinical experience

Onkologie

Volumn 29, Issue 7, 2006, Pages 314-318

  Frost, Annette ^a   Gmehling, Daniela ^a   Azemar, Marc ^a   Unger, Clemens ^a   Mross, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anthracyclines; Extravasation; ICRF

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; RAZOXANE; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CASE REPORT; CONVALESCENCE; DEBRIDEMENT; DISEASE SEVERITY; DRUG SAFETY; ERYTHEMA; EXTRAVASATION; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; OROPHARYNX CANCER; PAIN; RASH; TISSUE NECROSIS; TREATMENT OUTCOME;

AGED; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RAZOXANE; TREATMENT OUTCOME;

EID: 33745785058     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093480     Document Type: Article

References (16)

1. Mross K: Klinische und pharmakologische Untersuchungen zur Pharmakokinetik, Metabolisierung, Pharmakodynamik und Toxizität von Anthrazyklinen; in Nagel GA, Farthmann EH, Sauer R: Aktuelle Onkologie 76, München, Zuckschwerdt, 1994.
2. Rudolph R, Larson DL: Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol 1987;5:1116-1126.
3. Kraft A, Weinig S, Edinger M, Berger DR, Winterhalter BR: Anthrazyklin-Extravasate. Onkologe 2000;6:674-686.
4. Langer SW, Seheste M, Jensen PB: Treatment of anthracycline extravasation with dexrazoxane. Clin Cancer Res 2000;6:3680-3686.
5. Burton KP: Evidence of direct toxic effects of free radicals on the myocardium. Free Radial Biol Med 1988;4:15-24.
6. Averbuch SD, Gaudiano G, Koch TH, Bachur NR: Doxorubicin-induced skin necrosis in the swine model: protection with a novel radical dimer. J Clin Oncol 1986;4:88-94.
7. Speyer JL, Green MD, Kramer E, Sanger J, Ward J, Dubin N: Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. New Engl J Med 1988;319:745-752.
8. Jensen JN, Lock-Andersen J, Langer SW, Mejer J: Dexrazoxane - a promising antidote in the treatment of accidental extravasation of anthracyclines. Scan J Plast Reconstr Surg Hand Surg 2003;37:174-175.
9. Saghir NE, Otrock Z, Mufarrij A, Mourad YA, Salem Z, Shamseddine A, Abbas J: Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing. Lancet Oncol 2004;5:320-321.
10. Olver IN, Aisner J, Hament A, Buchanan L, Bishop JF, Kaplan RS: A prospective study of topical sulfoxide for treating anthracycline extravasation. J Clin Oncol 1988;6:1732-1735.
11. Jacob SW, Kappel JE (eds): DMSO. München, Zuckschwerdt, 1989.
12. Ener RA, Meglathery SB, Styler M: Extravasation of systemic hemato-oncological therapies. Ann Oncol 2004;15:858-862.
13. Glunta R, Akpaloo J, Kovacs L, Biemer E: Technik der sukutanen Spülung bei hochtoxischen Paravasaten. Handchir Mikrochir Plast Chir 2002;34:399-402.
14. Mross K, Maessen P, van der Vijgh WJF, Gall H, Boven E, Pinedo HM: Pharmacokinetics and metabolism of epirubicin and doxorubicin in man. J Clin Oncol 1988;6:517-526.
15. Schrijvers DL: Extravasation: a dreaded complication of chemotherapy. Ann Oncol 2003;14(suppl 3):26-30.
16. Mader I, Fürst-Weger PR, Mader RM; Semenitz EI, Terkola R, Wassertheurer SM (eds): Paravasation von Zytostatika - Ein Kompendium für Prävention und Therapie. Wien, Springer, 2002.